P2Y(1), P2Y(2), P2Y(4), and P2Y(6) receptors are coupled to Rho and Rho kinase activation in vascular myocytes.
about
Polarized expression and function of P2Y ATP receptors in rat bile duct epitheliaUTP controls cell surface distribution and vasomotor activity of the human P2Y2 receptor through an epidermal growth factor receptor-transregulated mechanismThe P2Y2 nucleotide receptor requires interaction with alpha v integrins to access and activate G12.Smooth muscle specific Rac1 deficiency induces hypertension by preventing p116RIP3-dependent RhoA inhibition.Control of granule mobility and exocytosis by Ca2+ -dependent formation of F-actin in pancreatic duct epithelial cells.TRPM4 channels couple purinergic receptor mechanoactivation and myogenic tone development in cerebral parenchymal arterioles.Role of Rho kinase signalling in healthy and varicose human saphenous veins.Purines and pyrimidines are not involved in NANC relaxant responses in the rabbit vaginal wall.Uridine adenosine tetraphosphate-induced contraction is increased in renal but not pulmonary arteries from DOCA-salt hypertensive rats.RhoA and resistance artery remodeling.P2 receptors in cardiovascular regulation and diseaseUridine adenosine tetraphosphate induces contraction and relaxation in rat aorta.Rho-kinase inhibition reduces pressure-mediated autoregulatory adjustments in afferent arteriolar diameter.Physiology and pathophysiology of the vasopressin-regulated renal water reabsorption.Rho-kinase-mediated suppression of KDR current in cerebral arteries requires an intact actin cytoskeleton.Pannexin 1 channels link chemoattractant receptor signaling to local excitation and global inhibition responses at the front and back of polarized neutrophils.The P2Y2 receptor mediates uptake of matrix-retained and aggregated low density lipoprotein in primary vascular smooth muscle cells.Regulation of RhoGEF proteins by G12/13-coupled receptors.ATP, P2 receptors and the renal microcirculation.Emerging role of G protein-coupled receptors in microvascular myogenic tone.Rho-kinase: important new therapeutic target in cardiovascular diseases.Cucurbitacin IIa: a novel class of anti-cancer drug inducing non-reversible actin aggregation and inhibiting survivin independent of JAK2/STAT3 phosphorylation.Dual role of PKA in phenotypic modulation of vascular smooth muscle cells by extracellular ATP.Alterations in vasoconstrictor responses to the endothelium-derived contracting factor uridine adenosine tetraphosphate are region specific in DOCA-salt hypertensive ratsCalcium-dependent neuroepithelial contractions expel damaged cells from the developing brain.Actin filaments play a permissive role in the inhibition of store-operated Ca2+ entry by extracellular ATP in rat brown adipocytes.Integration of P2Y receptor-activated signal transduction pathways in G protein-dependent signalling networksActin cytoskeleton controls movement of intracellular organelles in pancreatic duct epithelial cells.Receptor-independent activation of Rho-kinase-mediated calcium sensitisation in smooth muscleEndothelial P2Y2 receptor regulates LPS-induced neutrophil transendothelial migration in vitroBinding of the P2Y2 nucleotide receptor to filamin A regulates migration of vascular smooth muscle cells.Mechanisms of coronary artery depolarization by uridine triphosphate.Pyrimidine nucleotides suppress KDR currents and depolarize rat cerebral arteries by activating Rho kinase.Up4A stimulates endothelium-independent contraction of isolated rat pulmonary artery.Prologue: low-molecular-weight GTPases in the heart and circulationP2Y6 regulates cytoskeleton reorganization and cell migration of C2C12 myoblasts via ROCK pathway.Rho kinase activity governs arteriolar myogenic depolarization.
P2860
Q28565286-AB6F9790-A675-4730-986C-3E73134A25A1Q30433404-3B3B8F4E-723C-48B3-87F0-9FBA63D9978FQ30488952-A2EE5592-5724-4120-B376-30CB72BE7081Q30618659-F617B0FD-B514-44D5-B104-6E38D61087D7Q34627375-B318AC3F-938D-4F56-8A8A-6CD5ACA93748Q34727246-8521344B-2734-4065-84D4-2A98414A594FQ35044567-D9D4491A-E1B2-4410-A81C-E34DF34F12E1Q35044655-A032EF3E-1865-4C3A-AAC2-656DD323A832Q35159887-1247D2B5-17CE-4881-B404-C61C3A10FC3AQ36038081-0B967958-67A0-4C8B-8354-154DCA4220CAQ36464824-E582D12A-C640-46C1-BEC8-593A4A1264FAQ37000898-16B3D057-CC54-4181-960A-DE2E0A24F06EQ37138832-DD892976-C79E-48F7-A483-F0034D7E75C4Q37145917-00CF95E8-10E5-459A-9722-486BAAE24303Q37162567-94B100C4-C4DB-4EB1-945F-04258EB0BA17Q37311948-54B2A594-34DE-45D5-BD70-E6D15236AE67Q37331185-D1F8449F-477F-4B14-A12B-BCE177FA9ABAQ37395997-6EC94446-0EC3-4B52-B91E-5B71C93FBFB7Q37417180-4BD36F7F-B862-4B87-B4B0-2281D9C2FE50Q37463630-F8BB13AF-BA38-40B8-A6BF-B80B21307DC9Q37881804-84F49BAE-D38E-4DFE-8C1B-B51A7A4C68F9Q39595661-06CD4FB6-05AE-4D9E-92BC-51F753EE17DDQ40538564-E9B0E8F4-3DF0-4E02-BC45-77F0524EB212Q40617162-478CE958-2F41-4206-BEDF-E6CBA6D06CE2Q41066783-64F94BA0-9699-4C91-9E9A-1D5FB55B0328Q41986818-E3D77572-9F68-4B83-A44B-BD3C3604FA46Q42150686-9D99B7C6-6806-4C4D-B8FD-9AE0F7A892D6Q42226005-E0D8DA05-6137-4DBB-B51D-CF35E84A66F4Q42256697-9D7D1F05-31A4-4C63-BD86-8D6556AE0B55Q42356876-8D37C620-8203-4E25-A368-025E0DC525D7Q42728956-D62FFB8B-0FB6-4B34-93F9-581204B5B445Q43610491-AE85E142-2AEE-4D7A-B140-87174D819F07Q44639144-116AB7A4-47B7-458D-82C8-0CCBA5079BFAQ46810065-E54F3B87-C13D-44B9-8961-80A698D9AC3EQ47236973-58095D1D-37F6-4308-9D80-9E057C76F441Q48226306-CDCD22DB-5FCA-4E14-8DA6-BDAE00851353Q49157136-5D484D11-AFA1-4D95-9578-98E31170CA5A
P2860
P2Y(1), P2Y(2), P2Y(4), and P2Y(6) receptors are coupled to Rho and Rho kinase activation in vascular myocytes.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
P2Y(1), P2Y(2), P2Y(4), and P2 ...... tivation in vascular myocytes.
@en
P2Y(1), P2Y(2), P2Y(4), and P2 ...... tivation in vascular myocytes.
@nl
type
label
P2Y(1), P2Y(2), P2Y(4), and P2 ...... tivation in vascular myocytes.
@en
P2Y(1), P2Y(2), P2Y(4), and P2 ...... tivation in vascular myocytes.
@nl
prefLabel
P2Y(1), P2Y(2), P2Y(4), and P2 ...... tivation in vascular myocytes.
@en
P2Y(1), P2Y(2), P2Y(4), and P2 ...... tivation in vascular myocytes.
@nl
P2093
P2860
P1476
P2Y(1), P2Y(2), P2Y(4), and P2 ...... ctivation in vascular myocytes
@en
P2093
A P Gadeau
C Cario-Toumaniantz
C Desgranges
E Scalbert
H Le Jeune
N Vaillant
P2860
P304
P356
10.1152/AJPHEART.2000.278.6.H1751
P577
2000-06-01T00:00:00Z